Pebblebrook Hotel Trust (PEB) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Jun, 2026Investment highlights and market positioning
Multi-year recovery supported by improving hotel demand, limited new supply, and a robust event calendar through 2028.
Estimated $90M Hotel EBITDA upside driven by urban recovery, redevelopment ROI, and management agreement savings.
Retained free cash flow of ~$115M in 2026 enables self-funded debt reduction and share repurchases.
Shares trade at a 21% discount to private-market NAV, implying 27% upside.
Portfolio repositioned toward resorts and East Coast, reducing urban concentration and enhancing earnings durability.
Operational and financial performance
Urban occupancy and EBITDA remain below 2019, with significant upside as demand normalizes and supply stays limited.
Urban recovery scenario projects ~$70M incremental Hotel EBITDA as occupancy improves to ~80%.
Major redevelopments and repositionings have delivered strong ROI, with $270M invested and $40M annualized ROI realized.
Balance sheet strengthened by asset sales, debt reduction, preferred equity retirement, and share repurchases since 2025.
Estimated 2026 retained free cash flow of $115M supports further debt reduction and investments.
Portfolio quality and flexibility
Nearly all hotels have undergone major renovations, improving asset quality and reducing near-term capital needs.
81% of properties are unencumbered by non-terminable management or brand agreements, providing flexibility.
90% of assets are owned fee simple or on government/non-profit ground leases, supporting liquidity and value.
Portfolio includes 43 hotels, with 35 unencumbered properties across 13 urban and resort markets.
Latest events from Pebblebrook Hotel Trust
- Q2 2024 outperformed on EBITDA and FFO, but RevPAR growth outlook was lowered amid ADR pressure.PEB
Q2 20248 Jul 2026 - 2024 results beat outlook with resort and redevelopment gains; 2025 faces LA fire headwinds but growth expected.PEB
Q4 20248 Jul 2026 - Q1 2026 outperformed with robust EBITDA growth and a raised outlook amid macro risks.PEB
Q1 20261 May 2026 - Redevelopment, portfolio repositioning, and capital discipline drive EBITDA growth and value.PEB
Investor presentation28 Apr 2026 - Key votes include trustee elections, auditor ratification, and enhanced shareholder rights.PEB
Proxy filing17 Apr 2026 - Proxy covers trustee elections, auditor ratification, say-on-pay, and enhanced shareholder rights.PEB
Proxy filing17 Apr 2026 - 2025 beat guidance on adjusted metrics; 2026 targets EBITDA growth and margin expansion.PEB
Q4 20257 Apr 2026 - Proxy covers trustee elections, auditor ratification, say-on-pay, and key ESG and governance initiatives.PEB
Proxy filing26 Mar 2026 - Q3 net income rebounded, RevPAR rose 2.7%, but storms led to a lower 2024 outlook.PEB
Q3 202415 Jan 2026